The effect of mosapride (5HT-4 receptor agonist) on insulin sensitivity and GLUT4 translocation

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages 329-334

  Nam, J S ^a   Nam, J Y ^b   Yoo, J S ^a   Cho, M ^a   Park, J S ^a   Ahn, C W ^a   Cha, B S ^a   Lee, E J ^a   Lim, S K ^a   Kim, K R ^a   Lee, H C ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

Glucose transport; IGT; Insulin sensitivity; Insulin signaling

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; MOSAPRIDE CITRATE; PLACEBO;

ADULT; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE TRANSLOCATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MUSCLE CELL; MUSCLE FIBRIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKELETAL MUSCLE;

ADULT; BENZAMIDES; BLOOD GLUCOSE; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; IMMUNOASSAY; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; MORPHOLINES; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN TRANSPORT; SINGLE-BLIND METHOD;

EID: 77649185789     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.12.021     Document Type: Article

References (31)

1. De Fronzo R.A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35 (1992) 389-497
2. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
3. Guma A., Zierath J.R., Wallberg-Henriksson H., and Klip A. Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am. J. Physiol. 268 (1995) E613-E622
4. White M.F. The insulin signaling system and the IRS proteins. Diabetologia 40 Suppl. 2 (1997) S2-S17
5. Tecott L., Shtrom S., and Julius D. Expression of a serotonin-gated ion channel in embryonic neural and nonneural tissues. Mol. Cell. Neurosci. 6 (1995) 43-55
6. Fischer Y., Thomas J., Kamp J., Jüngling E., Rose H., Carpéné, et al. 5-Hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction. J. Biol. Chem. 311 (1995) 575-583
7. Taniyama K., Makimoto N., Furuichi A., Sakurai-Yamashita Y., Nagase Y., Kaibara M., et al. Functions of peripheral 5-hydroxytryptamin receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J. Gastroenterol. 35 (2000) 575-582
8. Ueno N., Inui A., Asakawa A., Takao F., Komatsu Y., Kotani K., et al. Mosapride, a HT-4 receptor agonist, improves insulin sensitivity and glycemic control in patients with type 2 diabetes mellitus. Diabetologia 45 (2002) 727-792
9. Curran M.P., and Robinson D.M. Mosapride in gastrointestinal disorders. Drugs 68 (2008) 981-991
10. + channel. J. Pharmacol. Exp. Ther. 289 (2001) 1007-1012
11. Mine Y., Yoshikawa T., Oku S., Nagai R., Yoshida N., and Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonist on gastrointestinal motility in vivo and in vitro. J. Pharmacol. Exp. Ther. 283 (1997) 1000-1008
12. Ueno N., and Satoh Y. Rapid effect of mosapride citrate, 5-HT4 receptor agonist, on fasting blood glucose in Type 2 diabetes patients. J. Diabetes Complications 23 (2009) 255-256
13. Horaceck J., Kuzmiakova M., Hoschl C., Andel M., and Bahbohn R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology 24 (1999) 785-797
14. Fronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (1979) E214-E223
15. Henry R.R., Abrams L., Nikoulina S., and Ciaraldi T.P. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects: comparison using human skeletal muscle cell cultures. Diabetes 44 (1995) 936-946
16. Bilan P.J., Mitsumoto Y., Ramlal T., and Klip A. Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells. Translocation and biosynthesis. FEBS Lett. 298 (1992) 285-290
17. Gulli G., Ferrannini E., Stern M., Haffner S., and DeFronzo R.A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41 (1992) 1575-1586
18. Gautier J.F., Wilson C., Weyer C., Mott D., Knowler W.C., Cavaghan M., et al. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes 50 (2001) 1828-1833
19. Vendrame F., and Gottlieb P.A. Prediabetes: prediction and prevention trials. Endocrinol. Metab. Clin. North Am. 33 (2004) 75-92
20. DeFronzo R.A. The triumvirate: β-cell, muscle, liver. Diabetes 37 (1988) 667-687
21. Garvey W.T., Maianu L., Zhu J.H., Brechtel-Hook G., Wallace P., and Baron A.D. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J. Clin. Invest. 101 (1998) 2377-2386
22. Kahn B.B. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 89 (1992) 1367-1374
23. Hill M.M., Clark S.F., Tucker D.F., Birnbaum M.J., James D.E., and Macaulay S.L. A role for protein kinase β/Akt 2 in insulin-stimulated Glut4 translocation in adipocytes. Mol. Cell. Biol. 19 (1999) 7771-7781
24. Kohn A.D., Summers S.A., Birnbaum M.J., and Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3/L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271 (1996) 31372-31378
25. Bandyopadhyay G., Standaert M.L., Zhao L., Yu B., Avignon A., Galloway L., et al. Activation of protein kinase C (α,β,ζ) by insulin in 3T3/L1 cells: transfection studies suggest a role for PKC-ζ in glucose transport. J. Biol. Chem. 272 (1997) 2551-2558
26. Bandyopadhyay G., Standaert M.L., Kikkawa U., Ono Y., Moscat J., and Farese R.V. Effects of transiently expressed atypical (ζ,λ), conventional (α,β) and novel (θ,ι) protein kinase C isoforms on insulin-stimulated translocation of opitope-tagged Glut4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-ζ and C-λ. J. Biol. Chem. 337 (1999) 461-470
27. Bjornholm M., Kawano Y., Lehtihet M., and Zierath J.R. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46 (1997) 524-527
28. Krook A., Roth R.A., Jiang X.J., Zierath J.R., and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47 (1998) 1281-1286
29. Kim Y.B., Nikoulina S.E., Ciaraldi R.P., Henry R.R., and Kahn B.B. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase in muscle in type 2 diabetes. J. Clin. Invest. 104 (1999) 733-741
30. Storgaard H., Song X.M., Jensen C.B., Madsbad S., Björnholm M., Vaag A., et al. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives with type 2 diabetes. Diabetes 50 (2001) 2770-2778
31. Vollenweider P., Menard B., and Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinasde C (ζ/λ) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 51 (2002) 1052-1059